Clinical Trial Update: Effect of Memantine on Radiotherapy-related Cognitive Impairment [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial investigating memantine for radiotherapy-related cognitive impairment; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Cognitive Impairment | Phase 2, Phase 3 | Status: UNKNOWN